Neuropsychological testing and biomarkers in the management of brain metastases

Radiation Oncology

Volumn 3, Issue 1, 2008, Pages

  Baschnagel, Andrew ^a   Wolters, Pamela L ^a   Camphausen, Kevin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

AGED; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; METASTASIS; METHODOLOGY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PROGNOSIS; PSYCHOLOGICAL ASPECT; RADIOSURGERY; REVIEW; TREATMENT OUTCOME;

AGED; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; RADIOSURGERY; RESEARCH DESIGN; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 53249137977     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-3-26     Document Type: Review

References (101)

1. Johnson JD Young B Demographics of brain metastasis Neurosurg Clin N Am 1996, 7:337-344. 8823767
2. Zimm S Wampler GL Stablein D Hazra T Young HF Intracerebral metastases in solid-tumor patients: Natural history and results of treatment Cancer 1981, 48:384-394. 10.1002/ 1097-0142(19810715)48:2<384::AID-CNCR2820480227>3.0.CO;2-8 7237407
3. Cairncross JG Kim JH Posner JB Radiation therapy for brain metastases Ann Neurol 1980, 7:529-541. 10.1002/ana.410070606 7436358
4. Borgelt B Gelber R Kramer S Brady LW Chang CH Davis LW Perez CA Hendrickson FR The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 1980, 6:1-9. 6154024
5. Lagerwaard FJ Levendag PC Nowak PJ Eijkenboom WM Hanssens PE Schmitz PI Identification of prognostic factors in patients with brain metastases: a review of 1292 patients Int J Radiat Oncol Biol Phys 1999, 43:795-803. 10098435
6. Patchell RA Tibbs PA Regine WF Dempsey RJ Mohiuddin M Kryscio RJ Markesbery WR Foon KA Young B Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial Jama 1998, 280:1485-1489. 10.1001/jama.280.17.1485 9809728
7. Gaspar L Scott C Rotman M Asbell S Phillips T Wasserman T McKenna WG Byhardt R Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 1997, 37:745-751. 9128946
8. Sanghavi SN Miranpuri SS Chappell R Buatti JM Sneed PK Suh JH Regine WF Weltman E King VJ Goetsch SJ et al. Radiosurgery for patients with brain metastases: A multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method Int J Radiat Oncol Biol Phys 2001, 51:426-434. 11567817
9. Videtic GM Adelstein DJ Mekhail TM Rice TW Stevens GH Lee SY Suh JH Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases Int J Radiat Oncol Biol Phys 2007, 67:240-243. 17056192
10. Le Scodan R Massard C Mouret-Fourme E Guinebretierre JM Cohen-Solal C De Lalande B Moisson P Breton-Callu C Gardner M Goupil A et al. Brain metastases from breast carcinoma: Validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score Int J Radiat Oncol Biol Phys 2007, 69:839-845. 17544592
11. Sperduto PW Berkey B Gaspar LE Mehta M Curran W A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database Int J Radiat Oncol Biol Phys 2008, 70:510-514. 17931798
12. Ruderman NB Hall TC Use of Glucocorticoids in the Palliative Treatment of Metastatic Brain Tumors Cancer 1965, 18:298-306. 10.1002/ 1097-0142(196503)18:3<298::AID-CNCR2820180306>3.0.CO;2-H 14264031
13. Patchell RA Regine WF The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases Technol Cancer Res Treat 2003, 2:111-115. 12680791
14. Harwood AR Simson WJ Radiation therapy of cerebral metastases: A randomized prospective clinical trial Int J Radiat Oncol Biol Phys 1977, 2:1091-1094. 74375
15. Kurtz JM Gelber R Brady LW Carella RJ Cooper JS The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 1981, 7:891-895. 6171553
16. Borgelt B Gelber R Larson M Hendrickson F Griffin T Roth R Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 1981, 7:1633-1638. 6174490
17. Chatani M Teshima T Hata K Inoue T Prognostic factors in patients with brain metastases from lung carcinoma Strahlenther Onkol 1986, 162:157-161. 3515602
18. Haie-Meder C Pellae-Cosset B Laplanche A Lagrange JL Tuchais C Nogues C Arriagada R Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases Radiother Oncol 1993, 26:111-116. 10.1016/0167-8140(93)90091-L 7681997
19. Chatani M Matayoshi Y Masaki N Inoue T Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase Strahlenther Onkol 1994, 170:155-161. 8160096
20. Murray KJ Scott C Greenberg HM Emami B Seider M Vora NL Olson C Whitton A Movsas B Curran W A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the Radiation Therapy Oncology Group (RTOG) 9104 Int J Radiat Oncol Biol Phys 1997, 39:571-574. 9336134
21. Sawaya R Ligon BL Bindal AK Bindal RK Hess KR Surgical treatment of metastatic brain tumors J Neurooncol 1996, 27:269-277. 10.1007/ BF00165484 8847561
22. Patchell RA Tibbs PA Walsh JW Dempsey RJ Maruyama Y Kryscio RJ Markesbery WR Macdonald JS Young B A randomized trial of surgery in the treatment of single metastases to the brain N Engl J Med 1990, 322:494-500. 2405271
23. Vecht CJ Haaxma-Reiche H Noordijk EM Padberg GW Voormolen JH Hoekstra FH Tans JT Lambooij N Metsaars JA Wattendorff AR et al. Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery? Ann Neurol 1993, 33:583-590. 10.1002/ana.410330605 8498838
24. Noordijk EM Vecht CJ Haaxma-Reiche H Padberg GW Voormolen JH Hoekstra FH Tans JT Lambooij N Metsaars JA Wattendorff AR et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age Int J Radiat Oncol Biol Phys 1994, 29:711-717. 8040016
25. Mintz AH Kestle J Rathbone MP Gaspar L Hugenholtz H Fisher B Duncan G Skingley P Foster G Levine M A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis Cancer 1996, 78:1470-1476. 10.1002/ (SICI)1097-0142(19961001)78:7<1470::AID-CNCR14>3.0.CO;2-X 8839553
26. Petrovich Z Yu C Giannotta SL O'Day S Apuzzo ML Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery J Neurosurg 2002, 97:499-506. 12507085
27. Andrews DW Scott CB Sperduto PW Flanders AE Gaspar LE Schell MC Werner-Wasik M Demas W Ryu J Bahary JP et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial Lancet 2004, 363:1665-1672. 10.1016/ S0140-6736(04)16250-8 15158627
28. Aoyama H Shirato H Tago M Nakagawa K Toyoda T Hatano K Kenjyo M Oya N Hirota S Shioura H et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial JAMA 2006, 295:2483-2491. 10.1001/jama.295.21.2483 16757720
29. Manon R O'Neill A Knisely J Werner-Wasik M Lazarus HM Wagner H Gilbert M Mehta M Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: An Eastern Cooperative Oncology Group study (E 6397) J Clin Oncol 2005, 23:8870-8876. 10.1200/JCO.2005.01.8747 16314647
30. Shaw E Scott C Suh J Kadish S Stea B Hackman J Pearlman A Murray K Gaspar L Mehta M et al. RSR13 plus cranial radiation therapy in patients with brain metastases: Comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database J Clin Oncol 2003, 21:2364-2371. 10.1200/JCO.2003.08.116 12805339
31. Eyre HJ Ohlsen JD Frank J LoBuglio AF McCracken JD Weatherall TJ Mansfield CM Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. A Southwest Oncology Group study J Neurooncol 1984, 2:325-330. 10.1007/BF00178115 6397578
32. DeAngelis LM Currie VE Kim JH Krol G O'Hehir MA Farag FM Young CW Posner JB The combined use of radiation therapy and lonidamine in the treatment of brain metastases J Neurooncol 1989, 7:241-247. 10.1007/BF00172917 2677257
33. Komarnicky LT Phillips TL Martz K Asbell S Isaacson S Urtasun R A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916) Int J Radiat Oncol Biol Phys 1991, 20:53-58. 1993631
34. Phillips TL Scott CB Leibel SA Rotman M Weigensberg IJ Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: Report of RTOG trial 89-05 Int J Radiat Oncol Biol Phys 1995, 33:339-348. 7673021
35. Mehta MP Rodrigus P Terhaard CH Rao A Suh J Roa W Souhami L Bezjak A Leibenhaut M Komaki R et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases J Clin Oncol 2003, 21:2529-2536. 10.1200/ JCO.2003.12.122 12829672
36. Suh JH Stea B Nabid A Kresl JJ Fortin A Mercier JP Senzer N Chang EL Boyd AP Cagnoni PJ Shaw E Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases J Clin Oncol 2006, 24:106-114. 10.1200/JCO.2004.00.1768 16314619
37. Knisely JP Berkey B Chakravarti A Yung AW Curran WJ Jr Robins HI Movsas B Brachman DG Henderson RH Mehta MP A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118) Int J Radiat Oncol Biol Phys 2008, 71:79-86. 18164847
38. Antonadou D Paraskevaidis M Sarris G Coliarakis N Economou I Karageorgis P Throuvalas N Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases J Clin Oncol 2002, 20:3644-3650. 10.1200/JCO.2002.04.140 12202665
39. Kil WJ Cerna D Burgan WE Beam K Carter D Steeg PS Tofilon PJ Camphausen K In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide Clin Cancer Res 2008, 14:931-938. 10.1158/ 1078-0432.CCR-07-1856 18245557
40. DeAngelis LM Delattre JY Posner JB Radiation-induced dementia in patients cured of brain metastases Neurology 1989, 39:789-796. 2725874
41. DeAngelis LM Mandell LR Thaler HT Kimmel DW Galicich JH Fuks Z Posner JB The role of postoperative radiotherapy after resection of single brain metastases Neurosurgery 1989, 24:798-805. 10.1097/ 00006123-198906000-00002 2473409
42. Tofilon PJ Fike JR The radioresponse of the central nervous system: A dynamic process Radiat Res 2000, 153:357-370. 10.1667/ 0033-7587(2000)153[0357:TROTCN]2.0.CO;2 10798963
43. Schultheiss TE Kun LE Ang KK Stephens LC Radiation response of the central nervous system Int J Radiat Oncol Biol Phys 1995, 31:1093-1112. 7677836
44. Brown WR Blair RM Moody DM Thore CR Ahmed S Robbins ME Wheeler KT Capillary loss precedes the cognitive impairment induced by fractionated whole-brain irradiation: A potential rat model of vascular dementia J Neurol Sci 2007, 257:67-71. 10.1016/j.jns.2007.01.014 17316691
45. Mizumatsu S Monje ML Morhardt DR Rola R Palmer TD Fike JR Extreme sensitivity of adult neurogenesis to low doses of X-irradiation Cancer Res 2003, 63:4021-4027. 12874001
46. Gutierrez AN Westerly DC Tome WA Jaradat HA Mackie TR Bentzen SM Khuntia D Mehta MP Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: A planning study Int J Radiat Oncol Biol Phys 2007, 69:589-597. 17869672
47. Wefel JS Kayl AE Meyers CA Neuropsychological dysfunction associated with cancer and cancer therapies: A conceptual review of an emerging target Br J Cancer 2004, 90:1691-1696. 15150608
48. Tannock IF Ahles TA Ganz PA Van Dam FS Cognitive impairment associated with chemotherapy for cancer: Report of a workshop J Clin Oncol 2004, 22:2233-2239. 10.1200/JCO.2004.08.094 15169812
49. Spiegler BJ Bouffet E Greenberg ML Rutka JT Mabbott DJ Change in neurocognitive functioning after treatment with cranial radiation in childhood J Clin Oncol 2004, 22:706-713. 10.1200/JCO.2004.05.186 14966095
50. Butler RW Haser JK Neurocognitive effects of treatment for childhood cancer Ment Retard Dev Disabil Res Rev 2006, 12:184-191. 10.1002/ mrdd.20110 17061287
51. Klein M Heimans JJ Aaronson NK Ploeg van der HM Grit J Muller M Postma TJ Mooij JJ Boerman RH Beute GN et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: A comparative study Lancet 2002, 360:1361-1368. 10.1016/S0140-6736(02)11398-5 12423981
52. Brown PD Buckner JC O'Fallon JR Iturria NL Brown CA O'Neill BP Scheithauer BW Dinapoli RP Arusell RM Curran WJ et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination J Clin Oncol 2003, 21:2519-2524. 10.1200/JCO.2003.04.172 12829670
53. Folstein MF Folstein SE McHugh PR "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 1975, 12:189-198. 10.1016/0022-3956(75)90026-6 1202204
54. Regine WF Scott C Murray K Curran W Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: An analysis from Radiation Therapy Oncology Group Study 91-04 Int J Radiat Oncol Biol Phys 2001, 51:711-717. 11597813
55. Murray KJ Scott C Zachariah B Michalski JM Demas W Vora NL Whitton A Movsas B Importance of the mini-mental status examination in the treatment of patients with brain metastases: A report from the Radiation Therapy Oncology Group protocol 91-04 Int J Radiat Oncol Biol Phys 2000, 48:59-64. 10.1016/S0360-3016(00)00600-3 10924972
56. Corn BW Moughan J Knisely JP Fox SW Chakravarti A Yung WK Curran WJ Jr Robins HI Brachman DG Henderson RH et al. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118 Int J Radiat Oncol Biol Phys 2008, 71:71-78. 18164829
57. Aoyama H Tago M Kato N Toyoda T Kenjyo M Hirota S Shioura H Inomata T Kunieda E Hayakawa K Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone Int J Radiat Oncol Biol Phys 2007, 68:1388-1395. 17674975
58. Meyers CA Smith JA Bezjak A Mehta MP Liebmann J Illidge T Kunkler I Caudrelier JM Eisenberg PD Meerwaldt J Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial J Clin Oncol 2004, 22:157-165. 10.1200/JCO.2004.05.128 14701778
59. Chang EL Wefel JS Maor MH Hassenbusch SJ 3rd Mahajan A Lang FF Woo SY Mathews LA Allen PK Shiu AS Meyers CA A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone Neurosurgery 2007, 60:277-283. discussion 283-274 17290178
60. Li J Bentzen SM Renschler M Mehta MP Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function J Clin Oncol 2007, 25:1260-1266. 10.1200/JCO.2006.09.2536 17401015
61. Regine WF Schmitt FA Scott CB Dearth C Patchell RA Nichols RC Jr Gore EM Franklin RL 3rd Suh JH Mehta MP Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: Results of Radiation Therapy Oncology Group trial BR-0018 Int J Radiat Oncol Biol Phys 2004, 58:1346-1352. 10.1016/ j.ijrobp.2003.09.023 15050309
62. Kwok Y Won M Regine WF Mehta M Schmitt F Patchell RA Watkins-Bruner D Neurocognitive Impact of Whole Brain Radiation on Patients With Brain Metastases: Secondary Analysis of RTOG BR-0018 International Journal of Radiation Oncology Biology Physics 2007, 69:S103.
63. Li J Bentzen SM Li J Renschler M Mehta MP Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis Int J Radiat Oncol Biol Phys 2008, 71:64-70. 18406884
64. Meyers CA Weitzner MA Valentine AD Levin VA Methylphenidate therapy improves cognition, mood, and function of brain tumor patients J Clin Oncol 1998, 16:2522-2527. 9667273
65. Chan AS Cheung MC Law SC Chan JH Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis Cancer 2004, 100:398-404. 10.1002/cncr.11885 14716777
66. Shaw EG Rosdhal R D'Agostino RB Jr Lovato J Naughton MJ Robbins ME Rapp SR Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life J Clin Oncol 2006, 24:1415-1420. 10.1200/JCO.2005.03.3001 16549835
67. Gehring K Sitskoorn MM Aaronson NK Taphoorn MJ Interventions for cognitive deficits in adults with brain tumours Lancet Neurol 2008, 7:548-560. 10.1016/S1474-4422(08)70111-X 18485318
68. Herman MA Tremont-Lukats I Meyers CA Trask DD Froseth C Renschler MF Mehta MP Neurocognitive and functional assessment of patients with brain metastases: A pilot study Am J Clin Oncol 2003, 26:273-279. 10.1097/ 00000421-200306000-00014 12796600
69. Meyers CA Wefel JS The use of the mini-mental state examination to assess cognitive functioning in cancer trials: No ifs, ands, buts, or sensitivity J Clin Oncol 2003, 21:3557-3558. 10.1200/JCO.2003.07.080 12913103
70. Meyers CA Hess KR Yung WK Levin VA Cognitive function as a predictor of survival in patients with recurrent malignant glioma J Clin Oncol 2000, 18:646-650. 10653880
71. Ruff R Crouch J Neuropsychological test instruments in clinical trials Amsterdam: Swets & Zeitlinger 1991
72. Meyers CA Hess KR Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression Neuro Oncol 2003, 5:89-95. 1920671 12672280 10.1215/15228517-5-2-89
73. Mahoney FI Barthel DW Functional Evaluation: The Barthel Index Md State Med J 1965, 14:61-65. 14258950
74. Weitzner MA Meyers CA Gelke CK Byrne KS Cella DF Levin VA The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors Cancer 1995, 75:1151-1161. 10.1002/ 1097-0142(19950301)75:5<1151::AID-CNCR2820750515>3.0.CO;2-Q 7850714
75. Kaiser E Kuzmits R Pregant P Burghuber O Worofka W Clinical biochemistry of neuron specific enolase Clin Chim Acta 1989, 183:13-31. 10.1016/ 0009-8981(89)90268-4 2548772
76. Pol van de M Twijnstra A ten Velde GP Menheere PP Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma J Neurooncol 1994, 19:149-154. 10.1007/BF01306456 7964990
77. Jacot W Quantin X Boher JM Andre F Moreau L Gainet M Depierre A Quoix E Chevalier TL Pujol JL Brain metastases at the time of presentation of non-small cell lung cancer: A multi-centric AERIO analysis of prognostic factors Br J Cancer 2001, 84:903-909. 10.1054/bjoc.2000.1706 11286469
78. Kanner AA Marchi N Fazio V Mayberg MR Koltz MT Siomin V Stevens GH Masaryk T Aumayr B Vogelbaum MA Serum S100beta: A noninvasive marker of blood-brain barrier function and brain lesions Cancer 2003, 97:2806-2813. 10.1002/cncr.11409 12767094
79. Foerch C du Mesnil de Rochemont R Singer O Neumann-Haefelin T Buchkremer M Zanella FE Steinmetz H Sitzer M S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion J Neurol Neurosurg Psychiatry 2003, 74:322-325. 1738319 12588916 10.1136/ jnnp.74.3.322
80. Vogelbaum MA Masaryk T Mazzone P Mekhail T Fazio V McCartney S Marchi N Kanner A Janigro D S100beta as a predictor of brain metastases: Brain versus cerebrovascular damage Cancer 2005, 104:817-824. 10.1002/ cncr.21220 15971200
81. Kaskel P Berking C Sander S Volkenandt M Peter RU Krahn G S-100 protein in peripheral blood: A markeA for melanoma metastases: a prospective 2-center study of 570 patients with melanoma J Am Acad Dermatol 1999, 41:962-969. 10.1016/S0190-9622(99)70254-9 10570381
82. Manev H Favaron M Guidotti A Costa E Delayed increase of Ca2+ influx elicited by glutamate: Role in neuronal death Mol Pharmacol 1989, 36:106-112. 2568579
83. Castillo J Davalos A Noya M Progression of ischaemic stroke and excitotoxic aminoacids Lancet 1997, 349:79-83. 10.1016/ S0140-6736(96)04453-4 8996418
84. Serena J Leira R Castillo J Pumar JM Castellanos M Davalos A Neurological deterioration in acute lacunar infarctions: The role of excitatory and inhibitory neurotransmitters Stroke 2001, 32:1154-1161. 11340225
85. Hong JH Chiang CS Campbell IL Sun JR Withers HR McBride WH Induction of acute phase gene expression by brain irradiation Int J Radiat Oncol Biol Phys 1995, 33:619-626. 7558951
86. Wickremesekera JK Chen W Cannan RJ Stubbs RS Serum proinflammatory cytokine response in patients with advanced liver tumors following selective internal radiation therapy (SIRT) with (90)Yttrium microspheres Int J Radiat Oncol Biol Phys 2001, 49:1015-1021. 10.1016/ S0360-3016(00)01420-6 11240242
87. Castellanos M Castillo J Garcia MM Leira R Serena J Chamorro A Davalos A Inflammation-mediated damage in progressing lacunar infarctions: A potential therapeutic target Stroke 2002, 33:982-987. 10.1161/ hs0402.105339 11935048
88. Vila N Castillo J Davalos A Chamorro A Proinflammatory cytokines and early neurological worsening in ischemic stroke Stroke 2000, 31:2325-2329. 11022058
89. Chan LW Moses MA Goley E Sproull M Muanza T Coleman CN Figg WD Albert PS Menard C Camphausen K Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: A longitudinal study of protein kinetics throughout tumor progression and therapy J Clin Oncol 2004, 22:499-506. 10.1200/ JCO.2004.07.022 14752073
90. Linderholm B Grankvist K Wilking N Johansson M Tavelin B Henriksson R Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment J Clin Oncol 2000, 18:1423-1431. 10735889
91. Garbisa S Scagliotti G Masiero L Di Francesco C Caenazzo C Onisto M Micela M Stetler-Stevenson WG Liotta LA Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy Cancer Res 1992, 52:4548-4549. 1322794
92. Ohta Y Watanabe Y Murakami S Oda M Hayashi Y Nonomura A Endo Y Sasaki T Vascular endothelial growth factor and lymph node metastasis in primary lung cancer Br J Cancer 1997, 76:1041-1045. 9376264
93. Claffey KP Brown LF del Aguila LF Tognazzi K Yeo KT Manseau EJ Dvorak HF Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis Cancer Res 1996, 56:172-181. 8548760
94. Rosell A Alvarez-Sabin J Arenillas JF Rovira A Delgado P Fernandez-Cadenas I Penalba A Molina CA Montaner J A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke Stroke 2005, 36:1415-1420. 10.1161/01.STR.0000170641.01047.cc 15947272
95. Blair J Spreen O Predicting premorbid IQ: A revision of the National Adult Reading Test Clinical Neuropsychologist 1989, 3:129-136. 10.1080/ 13854048908403285
96. Brandt J Benedict R Hopkins Verbal Learning Test professional manual - revised Lutz, Psychological Assessment Resources, Inc 1991
97. Wechsler D Wechsler Adult Intelligence Scale San Antonio, TX: Psychological Corporation Third 1997
98. Ruff R Allen C Ruff 2 & 7 Selective Attention Test professional manual Lutz, Psychological Assessment Resources, Inc 1995
99. Reiten R Davidson L Clinical neuropsychology: Current status and applications New York: Winston/Wiley 1974
100. Spreen O Strauss E A compendium of neuropsychological tests: Administration, norms, and commentary New York: Oxford University Press 1991
101. Klove H Clinical Neuropsychology Med Clin North Am 1963, 47:1647-1658. 14078168